Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.

Ivanov I, Lo KC, Hawthorn L, Cowell JK, Ionov Y.

Oncogene. 2007 May 3;26(20):2873-84. Epub 2006 Nov 6.

PMID:
17086209
2.

Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling.

Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, Scott MS, Gramolini AO, Morris Q, Hallett MT, Rossant J, Hughes TR, Frey B, Emili A.

Cell. 2006 Apr 7;125(1):173-86.

3.

The reaper-binding protein scythe modulates apoptosis and proliferation during mammalian development.

Desmots F, Russell HR, Lee Y, Boyd K, McKinnon PJ.

Mol Cell Biol. 2005 Dec;25(23):10329-37.

4.

The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.

Krummel KA, Lee CJ, Toledo F, Wahl GM.

Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10188-93. Epub 2005 Jul 8.

5.

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Chen D, Kon N, Li M, Zhang W, Qin J, Gu W.

Cell. 2005 Jul 1;121(7):1071-83.

6.
7.

Insights into selective activation of p53 DNA binding by c-Abl.

Wei G, Li AG, Liu X.

J Biol Chem. 2005 Apr 1;280(13):12271-8. Epub 2005 Jan 20.

8.

p53 linear diffusion along DNA requires its C terminus.

McKinney K, Mattia M, Gottifredi V, Prives C.

Mol Cell. 2004 Nov 5;16(3):413-24.

9.

Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain.

Liu Y, Lagowski JP, Vanderbeek GE, Kulesz-Martin MF.

Cancer Biol Ther. 2004 Nov;3(11):1102-8. Epub 2004 Nov 24.

PMID:
15467437
10.

Immediate early gene X-1 interacts with proteins that modulate apoptosis.

Kumar R, Lutz W, Frank E, Im HJ.

Biochem Biophys Res Commun. 2004 Oct 29;323(4):1293-8.

11.

Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function.

Fojta M, Pivonkova H, Brazdova M, Nemcova K, Palecek J, Vojtesek B.

Eur J Biochem. 2004 Oct;271(19):3865-76.

12.
13.

The ubiquitin ligase COP1 is a critical negative regulator of p53.

Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM.

Nature. 2004 May 6;429(6987):86-92. Epub 2004 Apr 21.

PMID:
15103385
14.

Promoter-specific p53-dependent histone acetylation following DNA damage.

Kaeser MD, Iggo RD.

Oncogene. 2004 May 13;23(22):4007-13.

PMID:
15007388
15.

Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2259-64.

16.

Ricin triggers apoptotic morphological changes through caspase-3 cleavage of BAT3.

Wu YH, Shih SF, Lin JY.

J Biol Chem. 2004 Apr 30;279(18):19264-75. Epub 2004 Feb 11.

17.

Enhancement of p53 sequence-specific binding by DNA supercoiling.

Palecek E, Brázda V, Jagelská E, Pecinka P, Karlovská L, Brázdová M.

Oncogene. 2004 Mar 18;23(12):2119-27.

PMID:
14755248
18.

MDM2, an introduction.

Iwakuma T, Lozano G.

Mol Cancer Res. 2003 Dec;1(14):993-1000. Review.

19.

Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP.

Cancer Cell. 2003 Oct;4(4):321-8.

20.

Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper.

Colón-Ramos DA, Irusta PM, Gan EC, Olson MR, Song J, Morimoto RI, Elliott RM, Lombard M, Hollingsworth R, Hardwick JM, Smith GK, Kornbluth S.

Mol Biol Cell. 2003 Oct;14(10):4162-72. Epub 2003 Jul 11.

Supplemental Content

Support Center